Neurology

The Pharmacy Times® Neurology Resource Center is a comprehensive resource for clinical news and expert insights on disorders of the nervous system, including multiple sclerosis, Alzheimer disease, migraine, and Parkinson disease.

Latest News

FDA approves risperidone extended-release suspension for schizophrenia -- Image credit: wladimir1804 | stock.adobe.com
Amneal’s Injectable Extended-Release Suspension of Risperidone Receives FDA Approval to Treat Schizophrenia

September 4th 2025

FDA approves a new extended-release suspension formulation of risperidone for schizophrenia, expanding treatment options for patients.

Alzheimer disease and lecanemab -- Image credit: HalynaRom | stock.adobe.com
FDA Approves Subcutaneous Lecanemab Injection for Maintenance Dosing in Early Alzheimer Disease

September 2nd 2025

Mediterranean diet | Image Credit: © aamulya - stock.adobe.com
Mediterranean Diet Cuts Dementia-Linked Metabolites by 35% in APOE4 Carriers

August 25th 2025

FDA logo on smartphone -- Image credit: gguy | stock.adobe.com
FDA Issues CRL to Vatiquinone NDA Indicated For Friedreich Ataxia

August 19th 2025

Lithium orotate | Image Credit: © photo_gonzo - stock.adobe.com
Lithium Shows Potential as a Treatment for Alzheimer Disease

August 11th 2025

Latest CME Events & Activities
<1
...
4344454647
© 2025 MJH Life Sciences

All rights reserved.